Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid

Thrombosis and Haemostasis

Volumn 87, Issue 3, 2002, Pages 442-449

  Barrowcliffe, T W ^a   Fabregas P ^a   Jardi, M ^a   Cancelas, J ^a   Rabaneda, M ^a   Felez, J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Coagulation; Phospholipid; T cells

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9A; LIPOCORTIN 5; PHOSPHOLIPID; STAUROSPORINE; THROMBIN; THROMBOPLASTIN; ANION; PHOSPHATIDYLSERINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASSAY; BINDING AFFINITY; BLOOD CLOTTING; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOBLASTOID CELL; MONOCYTE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; T LYMPHOBLAST; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; METABOLISM; PATHOLOGY; T LYMPHOCYTE; THROMBOPHILIA; ULTRASTRUCTURE;

ANIONS; APOPTOSIS; CELL MEMBRANE; FACTOR IXA; FACTOR VIII; HUMANS; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PROTEIN BINDING; T-LYMPHOCYTES; THROMBOPHILIA; THROMBOPLASTIN; TUMOR CELLS, CULTURED;

EID: 0036123255     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613024     Document Type: Article

References (43)

1. Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor
2. Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation
3. The role of phospholipids in the activation of factor X and prothrombin
4. The endotoxin-induced coagulant activity of human monocytes
5. Leukocyte procoagulant activity in man, as in vitro correlate of delayed-type hypersensitivity
6. Macrophage procoagulants
7. Tissue factor expression in human leukemic cells
8. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Relation to an unfavorable prognosis
9. Leukocyte procoagulant activity. Enhancement of production in vitro by IgG and antigen-antibody complexes
10. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity
11. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients
12. Phorbol esters induce the synthesis of thromboplastin activity in human monocytes
13. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue
14. Functional assembly of intrinisic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa
15. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes
16. Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systems
17. Inhibition of thrombin generation by heparin and LMW heparins: A comparison of chromogenic and clotting methods
18. The behavior of different factor VIII concentrates in a chromogenic factor X-activating system
19. 593 to cys mutation
20. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)
21. Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
22. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages
23. Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells
24. The activation of human blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets and monocytes
25. Interaction of factor VIII with phospholipids: Role of composition and negative charge
26. Specificity of phosphatidylserine-containing binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres)
27. The complexity of the phospholipid binding protein annexin V
28. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells
29. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes
30. Pathophysiologic implications of membrane phospholipid assymmetry in blood cells
31. Molecular cloning of human plasma membrane phospholipid scramblase: A protein mediating transbilayer movement of plasma membrane phospholipids
32. Zinc induces mixed types of cell death, necrosis, and apoptosis, in Molt-4 cells
33. Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis
34. Pathophysiology of the thrombophilic state in the cancer patient
35. Abnormalities of haemostasis in malignancy
36. Tissue factor expression in human leukocytes and tumor cells
37. Disseminated intravascular coagulation in acute leukemias at first diagnosis
38. Bleeding and thrombosis in acute lymphoblastic leukemia
39. Acute ischaemia of the lower limb: An unusual presenting feature of acute lymphoblastic leukaemia
40. Recurrent venous thrombosis as the presenting manifestation of acute lymphocytic leukemia: Leukemic cell procoagulant activity is not responsible for the hypercoagulable state
41. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface
42. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque
43. Regulation of the thrombotic potential of atheroma